Furadantin and interstitial lung disease Patient Reports February 13, 2012

Furadantin Side Effects Report #4978394-8
Furadantin side effect was reported by a Health Professional from FRANCE on Apr 05, 2006. Female patient, 93 years of age, was diagnosed with urinary tract infection  and was treated with Furadantin. After drug was administered, patient experienced the following side effects: cardiac failure acute, infection , interstitial lung disease. Furadantin dosage: unknown. During the same period patient was treated with PREVISCAN, CORDARONE, DILTIAZEM HYDROCHLORIDE, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

Furadantin Side Effects Report #4765775-0
Furadantin side effect was reported by a Health Professional from AUSTRALIA on Aug 24, 2005. Female patient, 84 years of age, was diagnosed with urinary tract disorder, rheumatoid arthritis , essential hypertension and was treated with Furadantin. After drug was administered, patient experienced the following side effects: chest pain , chest x-ray abnormal, dyspnoea, fatigue, interstitial lung disease, pleural fibrosis, pulmonary fibrosis , renal impairment, respiratory failure. Furadantin dosage: 50 MG, EVERY 2DAY, ORAL. During the same period patient was treated with INDAPAMIDE, METHOTREXATE, FOLIC ACID, PERINDOPRIL, NAPROSYN, AMLODIPINE, RANIDITINE. Patient was hospitalized. Patient died on 05/16/2000.